Results 141 to 150 of about 2,179,427 (282)

Review Article: Albumin and Its Role in Inflammatory Bowel Disease: The Old, the New, and the Future

Journal of Gastroenterology and Hepatology, Volume 40, Issue 4, Page 808-820, April 2025.
ABSTRACT Background Circulating albumin concentrations are frequently measured in clinical practice. This review explores biochemical properties and physiological roles of albumin, its place in nutritional assessment, current understanding of perturbed circulating concentrations, and role in clinical management, with special focus on patients with ...
Karla Cameron, Anke L. Nguyen, David J. Gibson, Mark G. Ward, Miles P. Sparrow, Peter R. Gibson   +5 more
wiley   +1 more source

Review article: pharmacological treatment of the hepatorenal syndrome in cirrhotic patients [PDF]

, 2000
Dagher, Patch, Marley, Moore, Burroughs
openalex   +1 more source

Accuracy of Non‐Invasive Imaging Techniques for the Diagnosis of MASH in Patients With MASLD: A Systematic Review

Liver International, Volume 45, Issue 4, April 2025.
ABSTRACT Background and Aims Metabolic dysfunction‐associated steatotic liver disease (MASLD) is a growing public health problem. The secondary stage in MASLD is steatohepatitis (MASH), the co‐existence of steatosis and inflammation, a leading cause of progression to fibrosis and mortality. MASH resolution alone improves survival.
Jennifer Cathcart, Rachael Barrett, James S. Bowness, Ashis Mukhopadhya, Ruairi Lynch, John F. Dillon   +5 more
wiley   +1 more source

Analysis of Risk Factors for Patients with Liver Cirrhosis Complicated with Spontaneous Bacterial Peritonitis

Iranian Journal of Public Health, 2018
Background: We aimed to explore risk factors for patients with liver cirrhosis complicated with spontaneous bacterial peritonitis (SBP). Methods: The clinical data of 195 patients with liver cirrhosis complicated with SBP (study group), admitted from ...
Yuan WANG, Qingyu ZHANG
doaj  

Hepatorenal Syndrome: Aetiology, Diagnosis, and Treatment

Gastroenterology Research and Practice, 2015
Acute renal impairment is common in patients with chronic liver disease, occurring in approximately 19% of hospitalised patients with cirrhosis. A variety of types of renal impairment are recognised.
G. Low, G. J. M. Alexander, D. J. Lomas
doaj   +1 more source

Plasma levels of endothelin-1 in patients with the hepatorenal syndrome after successful liver transplantation [PDF]

, 2000
Sigrid Bachmann-Brandt, Isabel Bittner, P. Neuhaus, Ulrich Frei, Ralf Schindler   +4 more
openalex   +1 more source

Impact of GLP‐1RA on the Risk of Adverse Liver Outcomes Among Patients With Alcohol‐Associated Liver Disease and Type 2 Diabetes

Liver International, Volume 45, Issue 4, April 2025.
ABSTRACT Background and Aims We sought to characterise the impact of GLP‐1RA on adverse liver outcomes (ALO) among patients with alcohol‐associated liver disease (ALD) and Type 2 diabetes mellitus (T2DM). Methods Patients with T2DM newly diagnosed with ALD between 2013 and 2020 were identified using IBM MarketScan database and were categorised by GLP ...
Zayed Rashid, Selamawit Woldesenbet, Mujtaba Khalil, Sidharth Iyer, Muhammad Muntazir Mehdi Khan, Abdullah Altaf, Muhammad Musaab Munir, Giovanni Catalano, Khalid Mumtaz, Timothy M. Pawlik   +9 more
wiley   +1 more source

Invasive hemodynamic parameters in patients with hepatorenal syndrome

International Journal of Cardiology: Heart & Vasculature, 2022
Jerald Pelayo, K. Lo, Sahar Sultan, E. Quintero, E. Peterson, Grace Salacupa, Martin Angelo Zanoria, Geneva Guarin, B. Helfman, J. Sanon, Roy Mathew, A. Yazdanyar, V. Navarro, G. Pressman, J. Rangaswami   +14 more
semanticscholar   +1 more source

G‐CSF—In Patients With Severe Alcohol‐Associated Hepatitis: A Real‐World Experience

Liver International, Volume 45, Issue 4, April 2025.
ABSTRACT Background and Aims Severe alcohol‐associated hepatitis (SAH) is associated with high short‐term mortality, and failure of response to corticosteroids is associated with a mortality of ~70%–80% within 6 months. Granulocyte colony‐stimulating factor (G‐CSF) has been studied in steroid non‐responders; however, the data are limited.
Ritu Raj Singh, Puneet Chhabra, Sonu Dhillon   +2 more
wiley   +1 more source

TERLIPRESSIN VERSUS NORADRENALINE FOR HEPATORENAL SYNDROME. Economic evaluation under the perspective of the Brazilian Public Health System

Arquivos de Gastroenterologia
Background - Terlipressin and noradrenaline are the best studied treatments for hepatorenal syndrome, and there is no evidence of superiority of one over the other regarding to efficacy.
Ângelo Zambam de MATTOS, Angelo Alves de MATTOS, Rodrigo Antonini RIBEIRO   +2 more
doaj   +1 more source